Evidence map›Paper›PMID 38130035›Full record

ArticleEuropean journal of neurology2024

Peripheral immunity changes are associated with neurodegeneration and worse clinical outcome in idiopathic normal pressure hydrocephalus.

Jacopo Bissacco, Clara Simonetta, Davide Mascioli, Henri Zenuni, Roberta Bovenzi, Piergiorgio Grillo, Francesca Di Giuliano, Alessandro Stefani, Nicola Biagio Mercuri, Tommaso Schirinzi

Open access · hybridAbstract read
In one paragraph

Article in European journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Osteoporosis in older patients with idiopathic normal pressure hydrocephalus.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Jacopo BissaccoUnit of Neurology, Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.
Clara SimonettaUnit of Neurology, Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.
Davide MascioliUnit of Neurology, Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.
Henri ZenuniUnit of Neurology, Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.
Roberta BovenziUnit of Neurology, Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.
Piergiorgio GrilloDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Francesca Di GiulianoUnit of Neuroradiology, Department of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy.
Alessandro StefaniUnit of Neurology, Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.ORCID 0000-0002-1806-8922
Nicola Biagio MercuriUnit of Neurology, Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.
Tommaso SchirinziUnit of Neurology, Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.ORCID 0000-0002-2517-6278
University of Rome Tor Vergata · ITAOL (United States) · US

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca PNRR-M4C2-I1.3 Project PE_00000019 "HEAL ITALIA"
6 · The paper itself

Abstract

background and purposeIdiopathic normal pressure hydrocephalus (iNPH) pathogenesis is multifactorial. Systemic inflammation might have a role in gathering clinical-pathological trajectories. We aimed to shape the peripheral immune profile of iNPH and establish correlations with cerebrospinal fluid (CSF) markers, ventricular enlargement, and clinical outcomes.

methodsWe conducted a single-center retrospective-longitudinal study, including 38 iNPH patients and 38 controls. Baseline iNPH Grading Scale and modified Rankin Scale (mRS) scores were collected with peripheral blood cell count, CSF amyloid-β42 (Aβ42), total tau (t-tau), phosphorylated-181-tau, and Evans index. Depending on 5-year outcome, iNPH patients were grouped into "poor outcome" (PO; mRS ≥ 5) and "favorable outcome" (FO; mRS < 5). Biomarkers were compared and correlated with each other. Receiver operating characteristic analysis was performed.

resultsiNPH patients compared to controls had higher neutrophil-to-lymphocyte ratio (NLR; 2.43 ± 1.04 vs. 1.61 ± 0.47, p < 0.001), higher neutrophils (4.22 ± 0.86 1000/mL vs. 3.48 ± 1.34, p = 0.033), and lower lymphocytes (1.45 ± 0.55 1000/mL vs. 2.07 ± 0.86, p = 0.038), with the expected CSF biomarkers signature. In the patients' cohort, NLR was associated directly with t-tau and inversely with Aβ42. NLR directly correlated with Evans index. PO patients compared to those with FO had higher NLR (3.25 ± 1.40 vs. 2.01 ± 0.77, p = 0.035) and higher t-tau (274.76 ± 114.39 pg/mL vs. 150.28 ± 72.62, p = 0.017), with an area under the curve of 0.786 and 0.793, respectively.

conclusionsiNPH patients present a proinflammatory state associated with neurodegeneration and predicting poor clinical outcome. Systemic inflammation represents a factor in the clinical-pathological progression of iNPH, and the NLR emerges as a potential prognostic index.

Indexed as

Hydrocephalus, Normal PressureAmyloid beta-PeptidesBiomarkersHumansInflammationLongitudinal StudiesRetrospective Studiestau ProteinsAmyloid beta-PeptidesBiomarkerstau Proteinscerebrospinal fluid biomarkersidiopathic normal pressure hydrocephalusimmunityinflammationneutrophil-to-lymphocyte ratio

Identifiers

PMID38130035
PMCPMC11235958
OpenAlexW4390110682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.